Skip to content

Prospective study for preoperative factors to predict development of intimal hyperplasia in autologous vein graft.

Prospective study for preoperative factors to predict development of intimal hyperplasia in autologous vein graft. - Predict IH

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000019121
Enrollment
120
Registered
2015-09-26
Start date
2015-02-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Arteriosclerosis obliterans Burger disease Arterial occlusion Traumatic arterial injury Collagen disease associated vasculitis etc.

Interventions

None listed

Sponsors

Asahikawa Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) In routine care, patients with peripheral vascular disease needed autologous vein bypass grafting as operative material to rebuild circulation. 2) Patients 20 years of age and older who are able to agree with a will of theirs own.

Exclusion criteria

Exclusion criteria: 1) Patients with lack in communication skills. 2) Patients who can not be followed for one year after bypass surgery. 3) Patients with extensive tissue loss proximally exceeding ankle joint. 4) Patients judged inadequate to join the study by attending doctor.

Design outcomes

Primary

MeasureTime frame
Occurrence of significant stenosis or occlusion of vein graft within one year after bypass surgery

Secondary

MeasureTime frame
Indicated below. 1) Major adverse cardiac events (MACE) 2) Major adverse limb events (MALE) 3) Postoperative death 4) Graft patency 5) Limb salvage rate 6) Ulcer healing rate

Countries

Japan

Contacts

Public ContactShinsuke Kikuchi

Asahikawa Medical University Division of Vascular Surgery, Department of Surgery

kikuchi@asahikawa-med.ac.jp0166-68-2494

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026